Revised SPC: Norditropin (somatropin) products
SPC now highlights that although rare, pancreatitis should be considered in somatropin-treated patients who develop abdominal pain, especially in children. It also now includes gynecomastia in adults and children as an uncommon adverse effect
Source:
electronic Medicines compendium